14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
FLR vs ECG: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Everus Construction Group, Inc. (ECG) is the stronger overall head-to-head candidate over Fluor Corporation (FLR) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FLR carries a Unified Composite Score of 43.3/100 (HOLD) at $48.20 (14.9x Forward P/E, 2.1% operating margin), whereas ECG carries 52.6/100 (HOLD) at $82.50 (11.9x Forward P/E, 8.2% operating margin).
Technical & Structure Timing Caution: FLR trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 49.3); meanwhile ECG is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 38.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Engineering & Construction value chain with $4.5B market capitalization and 8.2% operating margin.
OpEx & R&D Reinvestment5.4% of Rev ($252M)
90D Engineering Disclosures0 Published
Investor FAQ FLR vs ECG Key Questions & Quantitative Answers
As of Nov 16, 2026, Everus Construction Group, Inc. (ECG) is the stronger overall head-to-head candidate over Fluor Corporation (FLR) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FLR carries a Unified Composite Score of 43.3/100 (HOLD) at $48.20 (14.9x Forward P/E, 2.1% operating margin), whereas ECG carries 52.6/100 (HOLD) at $82.50 (11.9x Forward P/E, 8.2% operating margin). Technical & Structure Timing Caution: FLR trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 49.3); meanwhile ECG is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 38.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ECG leads the Growth & Scale pillar: FLR posts +10.5% YoY revenue growth and -94.5% YoY earnings growth on $15.9B TTM revenue (3.3% gross margin, 2.1% operating margin), compared with ECG at +40.3% YoY revenue growth and +61.3% YoY earnings growth on $4.66B TTM revenue (13.6% gross margin, 8.2% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), FLR cumulative revenue shifted -17.8% while ECG shifted +38.9%. In operating R&D and SG&A reinvestment, FLR deploys 1.2% of Rev ($191M) (0 90-day corporate R&D disclosures) versus 5.4% of Rev ($252M) (0 disclosures) for ECG.
ECG screens cheaper on headline valuation multiples. FLR trades at 14.9x Forward P/E, 15.7x Trailing P/E, 0.31x PEG, and 0.3x EV/Revenue (-2.7% FCF margin), whereas ECG trades at 11.9x Forward P/E, 15.4x Trailing P/E, N/M PEG, and 1.0x EV/Revenue (5.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FLR (-27.4% ROE) versus ECG (40.3% ROE) capital efficiency.
In options market volatility and institutional positioning, FLR carries 45.0% implied volatility (22nd %ile, Compressed (<25th %ile)), a 0.34x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.65β · 52% Vol realized risk). By comparison, ECG carries 63.2% implied volatility (5th %ile, Compressed (<25th %ile)), a 0.23x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (2.22β · 130% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.